Semaglutide’s liver protection isn’t just from weight loss—it directly targets blood vessel cells in the liver to reduce fat, inflammation, and fibrosis, even when weight stays the same. https://s.fitbodyscience.com/U488y8
Correlational — new studies may shift this
Links are real but observational — association, not proof of cause.
Semaglutide protects the liver in mice with MASH even without weight loss by directly targeting blood vessel cells.
The study linked in the post found that semaglutide works directly on blood vessel cells in the liver to protect it, not just by causing weight loss. Other research also supports this, showing that semaglutide reduces liver fat, inflammation, and scarring in mice with fatty liver disease even when the mice don't lose weight. Both lines of evidence match the claim exactly, so the mechanism seems to be real in these animal models.
So basically, in mice, semaglutide's liver benefits go beyond just weight loss — it actually targets cells in liver blood vessels to ease MASH.
Click any claim to see the full scientific analysis
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.